검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Cytokine-induced memory-like natural killer cells (Cytokine-induced memory-like natural killer cells) Biohaven Pharmaceuticals, Inc.·Advanced Melanoma 12 trials |
|---|---|
Overview Program | Cytokine-induced memory-like natural killer cells |
Overview Company | Biohaven Pharmaceuticals, Inc. |
Overview Modality | CGT |
Overview Target | Advanced Melanoma |
Overview Indication | Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Toxicology Major finding | Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.. Natural killer (NK) cells are an emerging cellular immunotherapy for patients with acute myeloid leukemia (AML); however, the best approach to maximize NK cell antileukemia potential is unclear. Cytokine-induced memory-like NK cells differentiate after a brief preactivation with interleukin-12 (… |
Toxicology CRS | Reported |
Clinical Data Tier / Score | A · 21 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 5월 22일 (53일 전 · 갱신 권장) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Cytokine-induced memory-like natural killer cells (Cytokine-induced memory-like natural killer cells) Biohaven Pharmaceuticals, Inc.·Advanced Melanoma 12 trials |
|---|---|
Overview Program | Cytokine-induced memory-like natural killer cells |
Overview Company | Biohaven Pharmaceuticals, Inc. |
Overview Modality | CGT |
Overview Target | Advanced Melanoma |
Overview Indication | Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Toxicology Major finding | Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.. Natural killer (NK) cells are an emerging cellular immunotherapy for patients with acute myeloid leukemia (AML); however, the best approach to maximize NK cell antileukemia potential is unclear. Cytokine-induced memory-like NK cells differentiate after a brief preactivation with interleukin-12 (… |
Toxicology CRS | Reported |
Clinical Data Tier / Score | A · 21 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 5월 22일 (53일 전 · 갱신 권장) |
추천 비교
추천 비교